Literature DB >> 34642871

CircNCX1: the "Lord of the Ring" in the Heart - Insight into Its Sequence Characteristic, Expression, Molecular Mechanisms, and Clinical Application.

Lin Ding1, Mengyang Li1, Fuqing Yang1, Jianxun Wang2.   

Abstract

Circular RNAs (circRNAs) are covalently closed single-stranded RNAs with regulatory activity and regarded as new types of therapeutic targets in diseases such as cancers. By means of RNA-Seq technology, numerous cardiac circRNAs were discovered. Although some candidates were detected to involve in heart disease in murine model, relative low sequence conservation and expression level of their human homologs might result in an insignificant, even distinct effect in the human heart. Therefore, the therapeutic significance of circRNAs should be more strictly considered. It is also necessary to discuss which circRNA is suitable for being applied in heart disease treatment. Here, we are willing to introduce a ~ 1830 nt circular transcript generated from single exon of sodium/calcium exchanger 1 (ncx1) gene (also called solute carrier family 8 member A1, slc8a1), usually named circNCX1 or circSLC8A1, which is gradually coming into our view. circNCX1 is one of the most cardiac-enriched circRNAs. It is widely existent in vertebrate and relatively conserved, indicating its indispensability during the evolution of species. Indeed, circNCX1 was shown to involve in heart development by some expression analysis. It was further revealed that the dysregulation of circNCX1 is one of the key pathogeneses of heart diseases including ischemic cardiac injury and hypertrophic cardiomyopathy. To make the significance of circNCX1 in the heart clear, we comprehensively dissected circNCX1 in the aspects of its parental gene structure, conservation, biogenesis and expression profiles, function, molecular mechanisms, and clinical application in this review. New medicine or therapeutic schedules based on circNCX1 are expected in the future.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Circular RNA; Heart development; Heart disease; circNCX1; circSLC8A1

Mesh:

Substances:

Year:  2021        PMID: 34642871     DOI: 10.1007/s12265-021-10176-y

Source DB:  PubMed          Journal:  J Cardiovasc Transl Res        ISSN: 1937-5387            Impact factor:   3.216


  87 in total

1.  Histone Methyltransferase G9a Is Required for Cardiomyocyte Homeostasis and Hypertrophy.

Authors:  Roberto Papait; Simone Serio; Christina Pagiatakis; Francesca Rusconi; Pierluigi Carullo; Marta Mazzola; Nicolò Salvarani; Michele Miragoli; Gianluigi Condorelli
Journal:  Circulation       Date:  2017-08-04       Impact factor: 29.690

Review 2.  Roles of cardiac transcription factors in cardiac hypertrophy.

Authors:  Hiroshi Akazawa; Issei Komuro
Journal:  Circ Res       Date:  2003-05-30       Impact factor: 17.367

3.  Deciphering the Epigenetic Code of Cardiac Myocyte Transcription.

Authors:  Sebastian Preissl; Martin Schwaderer; Alexandra Raulf; Michael Hesse; Björn A Grüning; Claudia Köbele; Rolf Backofen; Bernd K Fleischmann; Lutz Hein; Ralf Gilsbach
Journal:  Circ Res       Date:  2015-06-23       Impact factor: 17.367

4.  The biogenesis and emerging roles of circular RNAs.

Authors:  Ling-Ling Chen
Journal:  Nat Rev Mol Cell Biol       Date:  2016-02-24       Impact factor: 94.444

Review 5.  Non-coding RNAs in cardiovascular diseases: diagnostic and therapeutic perspectives.

Authors:  Wolfgang Poller; Stefanie Dimmeler; Stephane Heymans; Tanja Zeller; Jan Haas; Mahir Karakas; David-Manuel Leistner; Philipp Jakob; Shinichi Nakagawa; Stefan Blankenberg; Stefan Engelhardt; Thomas Thum; Christian Weber; Benjamin Meder; Roger Hajjar; Ulf Landmesser
Journal:  Eur Heart J       Date:  2018-08-01       Impact factor: 29.983

6.  Circular RNAs are abundant, conserved, and associated with ALU repeats.

Authors:  William R Jeck; Jessica A Sorrentino; Kai Wang; Michael K Slevin; Christin E Burd; Jinze Liu; William F Marzluff; Norman E Sharpless
Journal:  RNA       Date:  2012-12-18       Impact factor: 4.942

7.  Circular RNAs are a large class of animal RNAs with regulatory potency.

Authors:  Sebastian Memczak; Marvin Jens; Antigoni Elefsinioti; Francesca Torti; Janna Krueger; Agnieszka Rybak; Luisa Maier; Sebastian D Mackowiak; Lea H Gregersen; Mathias Munschauer; Alexander Loewer; Ulrike Ziebold; Markus Landthaler; Christine Kocks; Ferdinand le Noble; Nikolaus Rajewsky
Journal:  Nature       Date:  2013-02-27       Impact factor: 49.962

Review 8.  Cardiac hypertrophy: a matter of translation.

Authors:  R D Hannan; A Jenkins; A K Jenkins; Y Brandenburger
Journal:  Clin Exp Pharmacol Physiol       Date:  2003-08       Impact factor: 2.557

9.  Characterization of RNase R-digested cellular RNA source that consists of lariat and circular RNAs from pre-mRNA splicing.

Authors:  Hitoshi Suzuki; Yuhong Zuo; Jinhua Wang; Michael Q Zhang; Arun Malhotra; Akila Mayeda
Journal:  Nucleic Acids Res       Date:  2006-05-08       Impact factor: 16.971

10.  Circular non-coding RNA ANRIL modulates ribosomal RNA maturation and atherosclerosis in humans.

Authors:  Lesca M Holdt; Anika Stahringer; Kristina Sass; Garwin Pichler; Nils A Kulak; Wolfgang Wilfert; Alexander Kohlmaier; Andreas Herbst; Bernd H Northoff; Alexandros Nicolaou; Gabor Gäbel; Frank Beutner; Markus Scholz; Joachim Thiery; Kiran Musunuru; Knut Krohn; Matthias Mann; Daniel Teupser
Journal:  Nat Commun       Date:  2016-08-19       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.